10-Q: LogicMark Reports Q3 Revenue Growth Amidst Increased Losses

Sentiment:

Quarterly Report


LogicMark, Inc. reported an 8% increase in Q3 revenue and a 9% increase for the nine months ended September 30, 2025, driven by new product sales, despite widening net losses and increased cash burn from operations.

Capital raiseIn February 2025, the company completed a public offering, selling units and pre-funded units consisting of common stock and warrants, generating gross proceeds of approximately $14.4 million.The company explicitly stated that it "may, if ever deemed necessary, raise funds in the future through equity or debt offerings to further accelerate the execution of its long-term strategic plan."
Worse than expectedThe company's net loss and operating loss both widened for the nine months ended September 30, 2025, compared to the prior year, indicating a deterioration in profitability.Cash used in operating activities increased, suggesting a higher operational cash burn.The delisting from Nasdaq to OTC Markets Group Inc. is generally considered a negative development for a publicly traded company, potentially impacting investor confidence and stock liquidity.

Summary

  • Revenue for the three months ended September 30, 2025, increased by 8% to $2,915,081, compared to $2,705,461 for the same period in 2024.
  • Revenue for the nine months ended September 30, 2025, increased by 9% to $8,360,116, compared to $7,652,813 for the same period in 2024.
  • Gross profit margin remained stable at 66% for the three months and 66% for the nine months ended September 30, 2025, compared to 67% for both periods in 2024.
  • Operating loss for the nine months ended September 30, 2025, increased to $(6,230,110) from $(5,476,129) in the prior year.
  • Net loss for the nine months ended September 30, 2025, widened to $(5,869,163) from $(5,302,205) in the prior year.
  • Cash used in operating activities for the nine months ended September 30, 2025, increased to $(3,419,756) from $(3,261,568) in the prior year.
  • The company completed a public offering in February 2025, generating gross proceeds of approximately $14.4 million from the sale of common stock and warrants.
  • As of September 30, 2025, cash and cash equivalents stood at $4.1 million, with an additional $7.6 million invested in U.S. government securities.
  • Working capital significantly improved to $11.1 million as of September 30, 2025, from $3.3 million as of December 31, 2024.
  • A 1-for-750 reverse stock split was effected on October 28, 2025, reducing outstanding common shares from approximately 576 million to 768,665.
  • The company's common stock transitioned from the Nasdaq Capital Market to the OTC Markets Group Inc. under the symbol LGMK effective June 2, 2025.

Sentiment

Score: 4

Explanation: While revenue growth is positive and liquidity has improved due to recent capital raises, the widening net losses, increased cash burn from operations, and the delisting from Nasdaq indicate significant underlying challenges. The company's long-term profitability remains a concern despite strategic shifts and product updates.

Positives

  • Revenue increased by 8% for the three months and 9% for the nine months ended September 30, 2025, driven by sales of Freedom Alert Mini units and the upgraded Guardian Alert 911 Plus.
  • Gross profit margins remained relatively stable at 66% for the three and nine months ended September 30, 2025.
  • Working capital significantly improved to $11.1 million as of September 30, 2025, from $3.3 million at December 31, 2024, enhancing liquidity.
  • The company believes it has sufficient capital to sustain operations for at least one year, supported by $4.1 million in cash and $7.6 million in government securities.
  • Advertising costs decreased by $0.1 million for the nine months ended September 30, 2025, due to a strategic shift from business-to-consumer to business-to-business sales.
  • Received a $0.1 million refund from the IRS for an employee retention credit during the nine months ended September 30, 2025.

Negatives

  • Net loss widened to $(5,869,163) for the nine months ended September 30, 2025, compared to $(5,302,205) for the same period in 2024.
  • Operating loss increased to $(6,230,110) for the nine months ended September 30, 2025, from $(5,476,129) in the prior year.
  • Cash used in operating activities increased to $(3,419,756) for the nine months ended September 30, 2025, indicating higher cash burn.
  • Selling and marketing expenses increased by $0.3 million for the nine months ended September 30, 2025, primarily due to new personnel hires.
  • General and administrative expenses increased by $0.7 million for the nine months ended September 30, 2025, driven by higher consulting costs and legal fees.
  • The company's common stock was delisted from the Nasdaq Capital Market and now trades on the OTC Markets Group Inc. as of June 2, 2025, which can impact liquidity and investor perception.
  • The accumulated deficit increased to $(115,033,799) as of September 30, 2025, from $(109,164,636) at December 31, 2024.

Risks

  • Inflationary trends may increase the cost of purchasing products from contract manufacturers, raw materials, component parts, and labor.
  • New or existing tariffs, trade restrictions, or retaliatory actions could adversely impact the ability to source components, manufacture products competitively, or sell products at acceptable prices.
  • The effectiveness of internal control systems is subject to inherent limitations, including faulty judgments, simple errors, circumvention by individuals or collusion, and management override, which could lead to undetected misstatements or fraud.
  • The company continues to generate operating losses and use cash in operations, which could necessitate future capital raises.

Future Outlook

The company believes it will have sufficient capital to sustain operations for at least one year following the filing date, based on its current cash and investment positions and projected cash flow. It may also raise additional funds through equity or debt offerings to accelerate the execution of its long-term strategic plan for product development and commercialization. The company is evaluating the impact of recently issued accounting pronouncements (ASU 2025-05, ASU 2024-03, ASU 2023-09) but does not believe their adoption will have a material impact on its financial statements and disclosures.

Management Comments

  • "We experienced an 8% and 9% increase in revenue for the three and nine months ended September 30, 2025, respectively, as compared to the same periods ended September 30, 2024. The primary reason for the increase in revenue was due to continued higher sales of our Freedom Alert Mini units, launched in 2024 and our recently upgraded Guardian Alert 911 Plus."
  • "Given our cash and investment positions as of September 30, 2025, we believe we will have sufficient capital to sustain operations for at least twelve months from the date of the filing of our condensed financial statements."
  • "We may, if ever deemed necessary, raise funds in the future through equity or debt offerings to further accelerate the execution of our long-term strategic plan to develop and commercialize our new products."
  • "We believe that our business has been modestly impacted by inflationary trends during the past three fiscal years. However, recent activity by the U.S. administration concerning tariffs will likely increase our cost of fulfilment in the remainder of fiscal year 2025."
  • "We have been able to maintain our profit margins through higher productivity, better supply chain management, efficiency improvements, transferring much of our contract manufacturing from China and Hong Kong to Taiwan, and through other cost reduction programs."

Industry Context

LogicMark operates in the personal emergency response systems (PERS) and health communications devices market, focusing on connected care platforms and Internet of Things (IoT) technology. The company's strategy to shift from business-to-consumer (B2C) to business-to-business (B2B) sales, particularly with the U.S. Veterans Health Administration (VHA), aligns with a trend towards institutional partnerships for broader market penetration and potentially more stable revenue streams. The emphasis on modernizing remote monitoring for independent aging reflects a growing demand in an aging population, positioning the company within a relevant and expanding healthcare technology sector. The company's efforts to mitigate cost increases from inflation and tariffs by optimizing supply chain and manufacturing locations (e.g., shifting from China/Hong Kong to Taiwan) demonstrate adaptability in a dynamic global supply environment.

Comparison to Industry Standards

  • NA

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Senior Vice President of SalesNANew HireNAHiring to drive sales and marketing efforts, contributing to increased personnel costs.
Vice President of Business DevelopmentNANew HireNAHiring to drive sales and marketing efforts, contributing to increased personnel costs.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Reverse Stock SplitA 1-for-750 reverse stock split of outstanding Common Stock and Series C Redeemable Preferred Stock was effected on October 28, 2025. This followed a 1-for-25 reverse stock split on November 18, 2024.2025-10-28Reduced the number of outstanding shares, potentially increasing per-share metrics but often viewed negatively by the market as a measure to maintain listing compliance or improve share price appearance.
Preferred Stock Designation CancellationCertificates of withdrawal were filed on July 9, 2025, to eliminate and cancel all designations, rights, preferences, and limitations of Series H Preferred Stock and Series I Preferred Stock, after all shares were converted or redeemed.2025-07-09Simplified the capital structure by removing specific preferred stock series, potentially reducing complexity for investors.
Rights AgreementA Rights Agreement was entered into on November 1, 2024, entitling common stockholders to receive one right for each share, exercisable for Series G Preferred Stock, if a person or group acquires 15% or more of outstanding common stock without board approval.2024-11-01Designed to deter hostile takeovers by making such acquisitions more expensive and dilutive, protecting existing shareholder control.
Stock Incentive Plan UpdatesThe 2023 Stock Incentive Plan was approved on March 7, 2023, replacing the 2017 SIP. Stock options were modified during the nine months ended September 30, 2025, resulting in new exercise prices and incremental stock-based compensation expense.2023-03-07Aimed at aligning employee and director incentives with company performance, but modifications can impact compensation expense and potential dilution.

Legal Proceedings

  • The company is not presently a party to any legal proceedings that, in the opinion of management, would individually or taken together have a material adverse effect on its business, operating results, financial condition, or cash flows.

Related Party Transactions

  • NA

Stakeholder Impact

  • **Shareholders**: Experienced significant dilution and reverse stock splits, potentially impacting per-share value and market perception. The delisting to OTC Markets may reduce liquidity and investor interest. However, the capital raise provided necessary funding, and the Rights Agreement aims to protect against hostile takeovers.
  • **Employees**: Increased personnel wages in direct operating costs and R&D, and new hires in selling and marketing, suggest continued investment in human capital. Stock-based compensation plans are in place to incentivize employees.
  • **Customers**: Continued sales growth, particularly for new and upgraded products, indicates positive customer reception. The shift to B2B channels, including the VHA, suggests a focus on stable, larger customer segments.
  • **Creditors**: Improved working capital and a significant cash infusion from equity offerings enhance the company's ability to meet short-term obligations, reducing credit risk.
  • **Suppliers**: Efforts to diversify manufacturing locations (e.g., to Taiwan) and improve supply chain management aim to mitigate risks from tariffs and inflation, potentially leading to more stable relationships and costs.

Next Steps

  • Continue to execute the long-term strategic plan to develop and commercialize core products.
  • Potentially raise additional funds through equity or debt offerings to accelerate strategic plan execution.
  • Monitor and evaluate the impact of new accounting pronouncements (ASU 2025-05, ASU 2024-03, ASU 2023-09) on financial statements and disclosures.
  • Manage costs related to inflation and tariffs through productivity, supply chain management, efficiency improvements, and manufacturing location transfers.

Key Dates

DateDescription
2013-01-04Company's Long-Term Stock Incentive Plan (2013 LTIP) approved by stockholders.
2017-05-31Series C Redeemable Preferred Stock authorized.
2017-08-242017 Stock Incentive Plan (2017 SIP) approved by stockholders.
2023-01-032013 LTIP expired.
2023-03-072023 Stock Incentive Plan (2023 Plan) approved by stockholders; 2017 SIP terminated.
2023-06-01Company reincorporated in the State of Nevada.
2024-08-01SEC declared Form S-1 effective for the August Public Offering.
2024-08-02Securities purchase agreements for the August Public Offering dated.
2024-08-05Closing date of the August Public Offering.
2024-11-01Company entered into a Rights Agreement and filed a Certificate of Designation for Series G Non-Convertible Voting Preferred Stock.
2024-11-13Inducement and release agreements entered with Series B Holders; Certificates of Designation for Series H and I Preferred Stock filed.
2024-11-14Company issued Series H and I Preferred Stock to Series B Holders.
2024-11-18Company effected a 1-for-25 reverse split of its outstanding Common Stock and Series C Redeemable Preferred Stock.
2024-12-13Registration statement on Form S-3 registering the resale of Conversion Shares initially filed.
2024-12-15ASU 2023-09 (Income Taxes) effective for fiscal years beginning after this date.
2024-12-27Registration statement on Form S-3 declared effective by the SEC.
2024-12-31End of previous fiscal year.
2025-02-14SEC declared Form S-1 effective for the February Public Offering.
2025-02-18Closing date of the February Public Offering.
2025-03-27Stockholder approval obtained for the issuance of underlying shares in the February Offering.
2025-03-31Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC.
2025-04-30Company signed a lease agreement to renew warehouse space and equipment lease.
2025-06-01Common stock traded on the Nasdaq Capital Market through this date.
2025-06-02Common stock publicly quoted on OTC Markets Group Inc. under the symbol LGMK.
2025-07-09Certificates of withdrawal filed for Series H and I Preferred Stock designations.
2025-09-01Effective date of the renewed lease for warehouse space.
2025-09-30End of the current quarterly reporting period.
2025-10-28Company effected a 1-for-750 reverse split of its outstanding Common Stock and Series C Redeemable Preferred Stock (subsequent event).
2025-11-13Date of filing of the Quarterly Report on Form 10-Q.
2025-12-15ASU 2025-05 (Financial Instruments Credit Loss) effective for annual reporting periods beginning after this date.
2026-12-15ASU 2024-03 (Income Statement Expense Disaggregation Disclosures) effective for annual reporting periods beginning after this date.
2027-11-01Expiration date of the Rights Agreement, unless extended by stockholders or redeemed/exchanged by the Company.
2027-12-15ASU 2024-03 (Income Statement Expense Disaggregation Disclosures) effective for interim reporting periods within annual reporting periods beginning after this date.

Recommendation

hold

LogicMark presents a mixed financial picture. While revenue growth is encouraging, driven by new products and a strategic shift to B2B sales, the company continues to incur significant operating and net losses, alongside increased cash burn from operations. The recent capital raise has substantially improved liquidity and working capital, providing a runway for at least 12 months, which is a critical positive. However, the delisting from Nasdaq to the OTC Markets and the necessity of multiple reverse stock splits are strong negative signals regarding market confidence and share price stability. The company's ability to translate revenue growth into sustained profitability remains unproven. Investors should hold to observe if the strategic shifts and new product momentum can lead to a reduction in losses and positive cash flow from operations in future periods, while acknowledging the inherent risks of a company operating at a loss and trading on the OTC market.

Keywords

Personal Emergency Response Systems, PERS, Health Communications Devices, IoT, Connected Care Platform, Medical Alert Pendant, SEC Filing, 10-Q, LogicMark, LGMK, Reverse Stock Split, Equity Offering, Financial Results

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.